Aurora Cannabis Inc.
Aurora Cannabis Inc. (ACB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ACB · as of Jun 9, 2026
Key Statistics
Explore Aurora Cannabis Inc. Data
acb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 21.4%
The ACB analyst consensus is Hold, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $5.92, representing +73.61% upside from the current price of $3.41.
Competitors & Peers
acb competitorsACB
ACRS
BIOA
CGC
EDIT
HITIStock Performance
Full HistoryAbout Aurora Cannabis Inc.
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and interna…
what is aurora cannabis inc. · acb stock overview · aurora cannabis inc. company profile · who is aurora cannabis inc. ceo · acb NASDAQ · aurora cannabis inc. headquarters · aurora cannabis inc. business segments
About Stock Overview & Key Data
Aurora Cannabis Inc. (ACB) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Jul 15, 2014. As of the latest trading session, ACB stock price is $3.41, with a market capitalization of $201.6M. The stock has returned -41.41% over the past 12 months and -19.19% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Aurora Cannabis Inc. stock is Hold, with an average 12-month price target of $5.92. In fiscal year 2025, Aurora Cannabis Inc. reported revenue of $343.3M and net income of $1.6M. For detailed data — including Aurora Cannabis Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aurora Cannabis Inc. (ACB) stock price is $3.41. The stock is traded on NASDAQ under the ticker symbol ACB. The 52-week range is $3.07 – $6.67.